Beranda › Kelahiran Prematur › North Carolina
Uji klinis Kelahiran Prematur di North Carolina
8 studi untuk Kelahiran Prematur mencari peserta di lokasi di North Carolina.
Kota di North Carolina
Teks studi resmi (Bahasa Inggris)
Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care
- Duke University Eye Center, Durham
Menerima peserta
0 Days – 9 Months · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07738874PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
- University of North Carolina (UNC), Chapel Hill
- East Carolina University, Greenville
Menerima pesertaFase 1/2
7 Days – 28 Days · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT07101640Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
- Duke University, Durham
- East Carolina University, Greenville
Menerima pesertaStudi observasional
Usia 0 hingga 1 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT05685745Follow-up Visit of High Risk Infants
- Duke University, Durham
Menerima pesertaStudi observasional
18 Months – 26 Months · Semua jenis kelamin · Diperbarui 1 Jul 2026 · NCT00009633LATe Cerclage in High-risk Pregnancies (LATCH)
- Atrium Health Carolinas Medical Center, Charlotte
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 50 · Wanita · Diperbarui 29 Mei 2026 · NCT06036446Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
- University of North Carolina - Chapel Hill, Chapel Hill
- Duke University, Durham
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 14 ke atas · Wanita · Diperbarui 9 Apr 2026 · NCT06980025Generic Database of Very Low Birth Weight Infants
- Duke University, Durham
Menerima pesertaStudi observasional
14 Days · Semua jenis kelamin · Diperbarui 16 Mar 2026 · NCT00063063Imaging Retinal Vasculature in Infant Eyes
- Duke University, Durham
Menerima pesertaStudi observasional
2 Months · Semua jenis kelamin · Diperbarui 6 Okt 2025 · NCT05558059Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.